315 related articles for article (PubMed ID: 15253732)
1. Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure.
Wühl E; Mehls O; Schaefer F;
Kidney Int; 2004 Aug; 66(2):768-76. PubMed ID: 15253732
[TBL] [Abstract][Full Text] [Related]
2. [Renoprotective effect of ramipril in children with chronic renal failure--the experience of one centre].
Peco-Antić A; Virijević V; Paripović D; Babić D
Srp Arh Celok Lek; 2004 Oct; 132 Suppl 1():34-8. PubMed ID: 15615462
[TBL] [Abstract][Full Text] [Related]
3. Strict blood-pressure control and progression of renal failure in children.
; Wühl E; Trivelli A; Picca S; Litwin M; Peco-Antic A; Zurowska A; Testa S; Jankauskiene A; Emre S; Caldas-Afonso A; Anarat A; Niaudet P; Mir S; Bakkaloglu A; Enke B; Montini G; Wingen AM; Sallay P; Jeck N; Berg U; Caliskan S; Wygoda S; Hohbach-Hohenfellner K; Dusek J; Urasinski T; Arbeiter K; Neuhaus T; Gellermann J; Drozdz D; Fischbach M; Möller K; Wigger M; Peruzzi L; Mehls O; Schaefer F
N Engl J Med; 2009 Oct; 361(17):1639-50. PubMed ID: 19846849
[TBL] [Abstract][Full Text] [Related]
4. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia).
Lancet; 1997 Jun; 349(9069):1857-63. PubMed ID: 9217756
[TBL] [Abstract][Full Text] [Related]
5. Ramipril in the treatment of hypertension and proteinuria in children with chronic kidney diseases.
Seeman T; Dusek J; Vondrák K; Flögelová H; Geier P; Janda J
Am J Hypertens; 2004 May; 17(5 Pt 1):415-20. PubMed ID: 15110900
[TBL] [Abstract][Full Text] [Related]
6. Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN).
Ruggenenti P; Perna A; Mosconi L; Pisoni R; Remuzzi G
Kidney Int; 1998 May; 53(5):1209-16. PubMed ID: 9573535
[TBL] [Abstract][Full Text] [Related]
7. Add-on angiotensin receptor blockade with maximized ACE inhibition.
Agarwal R
Kidney Int; 2001 Jun; 59(6):2282-9. PubMed ID: 11380832
[TBL] [Abstract][Full Text] [Related]
8. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria.
Ruggenenti P; Perna A; Gherardi G; Garini G; Zoccali C; Salvadori M; Scolari F; Schena FP; Remuzzi G
Lancet; 1999 Jul; 354(9176):359-64. PubMed ID: 10437863
[TBL] [Abstract][Full Text] [Related]
9. Retarding progression of chronic renal disease: the neglected issue of residual proteinuria.
Ruggenenti P; Perna A; Remuzzi G;
Kidney Int; 2003 Jun; 63(6):2254-61. PubMed ID: 12753315
[TBL] [Abstract][Full Text] [Related]
10. Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury.
Ruggenenti P; Perna A; Gherardi G; Benini R; Remuzzi G
Am J Kidney Dis; 2000 Jun; 35(6):1155-65. PubMed ID: 10845831
[TBL] [Abstract][Full Text] [Related]
11. Long-term antiproteinuric and renoprotective efficacy and safety of losartan in children with proteinuria.
Ellis D; Vats A; Moritz ML; Reitz S; Grosso MJ; Janosky JE
J Pediatr; 2003 Jul; 143(1):89-97. PubMed ID: 12915830
[TBL] [Abstract][Full Text] [Related]
12. Early Proteinuria Lowering by Angiotensin-Converting Enzyme Inhibition Predicts Renal Survival in Children with CKD.
van den Belt SM; Heerspink HJL; Gracchi V; de Zeeuw D; Wühl E; Schaefer F;
J Am Soc Nephrol; 2018 Aug; 29(8):2225-2233. PubMed ID: 29930161
[No Abstract] [Full Text] [Related]
13. Effect of ramipril on ambulatory blood pressure and albuminuria in renal hypertension.
Soergel M; Verho M; Wühl E; Gellermann J; Teichert L; Schärer K
Pediatr Nephrol; 2000 Nov; 15(1-2):113-8. PubMed ID: 11095026
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive and renoprotective efficacy and safety of losartan. A long-term study in children with renal disorders.
Ellis D; Moritz ML; Vats A; Janosky JE
Am J Hypertens; 2004 Oct; 17(10):928-35. PubMed ID: 15485756
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of two ramipril and hydrochlorothiazide fixed-dose combination formulations in adults with stage 1 or stage 2 arterial hypertension evaluated by using ABPM.
Oigman W; Gomes MA; Pereira-Barretto AC; Póvoa R; Kohlmann O; Rocha JC; Nobre F
Clin Ther; 2013 May; 35(5):702-10. PubMed ID: 23623755
[TBL] [Abstract][Full Text] [Related]
16. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD
Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
[TBL] [Abstract][Full Text] [Related]
17. Achieving remission of proteinuria in childhood CKD.
Ruggenenti P; Cravedi P; Chianca A; Caruso M; Remuzzi G
Pediatr Nephrol; 2017 Feb; 32(2):321-330. PubMed ID: 27704256
[TBL] [Abstract][Full Text] [Related]
18. Maximal suppression of renin-angiotensin system in nonproliferative glomerulonephritis.
Iodice C; Balletta MM; Minutolo R; Giannattasio P; Tuccillo S; Bellizzi V; D'Amora M; Rinaldi G; Signoriello G; Conte G; De Nicola L
Kidney Int; 2003 Jun; 63(6):2214-21. PubMed ID: 12753310
[TBL] [Abstract][Full Text] [Related]
19. Selective endothelin-A receptor antagonism reduces proteinuria, blood pressure, and arterial stiffness in chronic proteinuric kidney disease.
Dhaun N; MacIntyre IM; Kerr D; Melville V; Johnston NR; Haughie S; Goddard J; Webb DJ
Hypertension; 2011 Apr; 57(4):772-9. PubMed ID: 21357275
[TBL] [Abstract][Full Text] [Related]
20. Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy. Collaborative Study Group.
Lewis JB; Berl T; Bain RP; Rohde RD; Lewis EJ
Am J Kidney Dis; 1999 Nov; 34(5):809-17. PubMed ID: 10561135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
